Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-19T12:37:12.973Z Has data issue: false hasContentIssue false

Section 4 - Antimicrobial-Resistant Organisms

Published online by Cambridge University Press:  02 April 2018

Ebbing Lautenbach
Affiliation:
University of Pennsylvania School of Medicine
Preeti N. Malani
Affiliation:
University of Michigan, Ann Arbor
Keith F. Woeltje
Affiliation:
Washington University School of Medicine, St Louis
Jennifer H. Han
Affiliation:
University of Pennsylvania School of Medicine
Emily K. Shuman
Affiliation:
University of Michigan, Ann Arbor
Jonas Marschall
Affiliation:
Washington University School of Medicine, St Louis
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: www.cdc.gov/drugresistance/threat-report-2013/. Accessed January 4, 2016.Google Scholar
Cosgrove, SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42 Suppl 2:S82S89.Google Scholar
National Nosocomial Infections Surveillance System. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control. 2002;30(8):458475.CrossRefGoogle Scholar
Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):114.CrossRefGoogle Scholar
Tattevin, P, Schwartz, BS, Graber, CJ, et al. Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2012;55(6):781788.Google Scholar
Dantes, R, Mu, Y, Belflower, R, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173(21):19701978.Google Scholar
Burton, DC, Edwards, JR, Horan, TC, et al. Methicillin-resistant Staphylococcus aureus central line-associated bloodstream infections in US intensive care units, 1997–2007. JAMA. 2009;301(7):727736.Google Scholar
Kallen, AJ, Mu, Y, Bulens, S, et al. Health care-associated invasive MRSA infections, 2005–2008. JAMA. 2010;304(6):641648.CrossRefGoogle ScholarPubMed
Roberts, RR, Hota, B, Ahmad, I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49(8):11751184.CrossRefGoogle Scholar
Kollef, MH, Sherman, G, Ward, S, et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999;115(2):462474.Google Scholar
Engemann, JJ, Carmeli, Y, Cosgrove, SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36(5):592598.Google Scholar
Cosgrove, SE, Qi, Y, Kaye, KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26(2):166174.CrossRefGoogle ScholarPubMed
Cosgrove, SE, Sakoulas, G, Perencevich, EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):5359.CrossRefGoogle ScholarPubMed
Rubin, RJ, Harrington, CA, Poon, A, et al. The economic impact of Staphylococcus aureus infection in new york city hospitals. Emerg Infect Dis. 1999;5(1):917.Google Scholar
Yaw, LK, Robinson, JO, Ho, KM. A comparison of long-term outcomes after methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect Dis. 2014;14(10):967975.Google Scholar
Edmond, MB, Ober, JF, Dawson, JD, et al. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis. 1996;23(6):12341239.Google Scholar
Bhavnani, SM, Drake, JA, Forrest, A, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36(3):145158.Google Scholar
Vergis, EN, Hayden, MK, Chow, JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Ann Intern Med. 2001;135(7):484492.Google Scholar
Cheah, AL, Spelman, T, Liew, D, et al. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization. Clin Microbiol Infect. 2013;19(4):E181E189.Google Scholar
Garbutt, JM, Ventrapragada, M, Littenberg, B, et al. Association between resistance to vancomycin and death in cases of enterococcus faecium bacteremia. Clin Infect Dis. 2000;30(3):466472.Google Scholar
Erlandson, KM, Sun, J, Iwen, PC, et al. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant enterococcus bacteremia. Clin Infect Dis. 2008;46(1):3036.Google Scholar
Chambers, HF. Methicillin-resistant staphylococci. Clin Microbiol Rev. 1988;1(2):173186.Google Scholar
Garcia-Alvarez, L, Holden, MT, Lindsay, H, et al. Methicillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11(8):595603.CrossRefGoogle ScholarPubMed
Salgado, CD, Farr, BM, Calfee, DP. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36(2):131139.CrossRefGoogle ScholarPubMed
Naimi, TS, LeDell, KH, Como-Sabetti, K, et al. Comparison of community- and health care–associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003;290(22):29762984.CrossRefGoogle ScholarPubMed
Said-Salim, B, Mathema, B, Braughton, K, et al. Differential distribution and expression of panton-valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol. 2005;43(7):33733379.Google Scholar
Diep, BA, Chambers, HF, Graber, CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med. 2008;148(4):249257.Google Scholar
Kaplan, SL, Hulten, KG, Gonzalez, BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40(12):17851791.Google Scholar
Liu, C, Graber, CJ, Karr, M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004–2005. Clin Infect Dis. 2008;46(11):16371646.Google Scholar
Popovich, KJ, Weinstein, RA, Hota, B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis. 2008;46(6):787794.CrossRefGoogle ScholarPubMed
Currie, A, Davis, L, Odrobina, E, et al. Sensitivities of nasal and rectal swabs for detection of methicillin-resistant Staphylococcus aureus colonization in an active surveillance program. J Clin Microbiol. 2008;46(9):31013103.Google Scholar
Sader, HS, Fey, PD, Limaye, AP, et al. Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Antimicrob Agents Chemother. 2009;53(10):41274132.CrossRefGoogle ScholarPubMed
Steinkraus, G, White, R, Vancomycin, Friedrich L. MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–2005. J Antimicrob Chemother. 2007;60(4):788794.Google Scholar
Wang, G, Hindler, JF, Ward, KW, et al. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44(11):38833886.Google Scholar
Holmes, NE, Turnidge, JD, Munckhof, WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis. 2011;204(3):340347.Google Scholar
Kalil, AC, Van Schooneveld, TC, Fey, PD, et al. Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis. JAMA. 2014;312(15):15521564.Google Scholar
Soriano, A, Marco, F, Martinez, JA, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46(2):193200.Google Scholar
Tenover, FC, Moellering, RC Jr. The rationale for revising the clinical and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007;44(9):12081215.Google Scholar
Maor, Y, Hagin, M, Belausov, N, et al. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis. 2009;199(5):619624.Google Scholar
Cui, L, Ma, X, Sato, K, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol. 2003;41(1):514.Google Scholar
Sievert, DM, Rudrik, JT, Patel, JB, et al. Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis. 2008;46(5):668674.Google Scholar
Wegener, H. Ending the use of antimicrobial growth promotes is making a difference. ASM News. 2003;69(9:)443448.Google Scholar
Werner, G, Coque, TM, Hammerum, AM, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Eur Surveill. 2008;13(47):19046.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. About antimicrobial resistance. Available at: www.cdc.gov/drugresistance/about.html. Accessed January 4, 2016.Google Scholar
Calfee, DP, Salgado, CD, Milstone, AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):772796.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Management of multidrug-resistant organisms in healthcare settings. Available at: www.cdc.gov/hicpac/mdro/mdro_0.html. Accessed January 4, 2016.Google Scholar
Centers for Disease Control and Prevention. Surveillance for C. difficile, MRSA, and other drug-resistant infections. Available at: www.cdc.gov/nhsn/acute-care-hospital/cdiff-mrsa/index.html. Accessed January 5, 2016.Google Scholar
Struelens, MJ, Hawkey, PM, French, GL, et al. Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. Clin Microbiol Infect. 2009;15(2):112119.Google Scholar
Malhotra-Kumar, S, Haccuria, K, Michiels, M, et al. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol. 2008;46(5):15771587.CrossRefGoogle ScholarPubMed
Boyce, JM PD, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;Oct 25;51(RR-16):145.Google ScholarPubMed
Centers for Disease Control and Prevention. Guideline for hand hygiene in health-care settings. Available at: www.cdc.gov/handhygiene/training.html. Accessed January 5, 2016.Google Scholar
Morgan, DJ, Murthy, R, Munoz-Price, LS, et al. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol. 2015;36(10):11631172.Google Scholar
Stelfox, HT, Bates, DW, Redelmeier, DA. Safety of patients isolated for infection control. JAMA. 2003;290(14):18991905.Google Scholar
Day, HR, Perencevich, EN, Harris, AD, et al. Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect. 2011;79(2):103107.Google Scholar
Harris, AD, Pineles, L, Belton, B, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA. 2013;310(15):15711580.Google ScholarPubMed
Occupational exposure to bloodborne pathogens–OSHA. final rule. Fed Regist. 1991;56(235):6400464182.Google Scholar
Boyce, JM, Potter-Bynoe, G, Chenevert, C, et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol. 1997;18(9):622627.Google Scholar
Smith, TL, Iwen, PC, Olson, SB, et al. Environmental contamination with vancomycin-resistant enterococci in an outpatient setting. Infect Control Hosp Epidemiol. 1998;19(7):515518.Google Scholar
Hardy, KJ, Oppenheim, BA, Gossain, S, et al. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients’ acquisition of MRSA. Infect Control Hosp Epidemiol. 2006;27(2):127132.Google Scholar
Snyder, GM, Thom, KA, Furuno, JP, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol. 2008;29(7):583589.Google Scholar
Puzniak, LA, Leet, T, Mayfield, J, et al. To gown or not to gown: The effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2002;35(1):1825.Google Scholar
Srinivasan, A, Song, X, Ross, T, et al. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol. 2002;23(8):424428.Google Scholar
Williams, C, McGraw, P, Schneck, EE, et al. Impact of universal gowning and gloving on health care worker clothing contamination. Infect Control Hosp Epidemiol. 2015;36(4):431437.Google Scholar
Vajravelu, RK, Guerrero, DM, Jury, LA, et al. Evaluation of stethoscopes as vectors of Clostridium difficile and methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2012;33(1):9698.CrossRefGoogle ScholarPubMed
de Gialluly, C, Morange, V, de Gialluly, E, et al. Blood pressure cuff as a potential vector of pathogenic microorganisms: a prospective study in a teaching hospital. Infect Control Hosp Epidemiol. 2006;27(9):940943.Google Scholar
Livornese, LL Jr, Dias, S, Samel, C, et al. Hospital-acquired infection with vancomycin-resistant enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117(2):112116.Google Scholar
Brooks, S, Khan, A, Stoica, D, et al. Reduction in vancomycin-resistant enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol. 1998;19(5):333336.CrossRefGoogle ScholarPubMed
Sexton, T, Clarke, P, O’Neill, E, et al. Environmental reservoirs of methicillin-resistant Staphylococcus aureus in isolation rooms: Correlation with patient isolates and implications for hospital hygiene. J Hosp Infect. 2006;62(2):187194.Google Scholar
Neely, AN, Maley, MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol. 2000;38(2):724726.Google Scholar
Drees, M, Snydman, DR, Schmid, CH, et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2008;46(5):678685.Google Scholar
Carling, PC, Parry, MM, Rupp, ME, et al. Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(11):10351041.Google Scholar
Hayden, MK, Bonten, MJ, Blom, DW, et al. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42(11):15521560.Google Scholar
Rupp, ME, Fitzgerald, T, Sholtz, L, et al. Maintain the gain: program to sustain performance improvement in environmental cleaning. Infect Control Hosp Epidemiol. 2014;35(7):866868.Google Scholar
Sehulster, L, Chinn, RY, CDC, et al. Guidelines for environmental infection control in health-care facilities: recommendations of CDC and the healthcare infection control practices advisory committee (HICPAC). MMWR Recomm Rep. 2003;52 (RR-10):142.Google ScholarPubMed
Carling, PC, Parry, MF, Bruno-Murtha, LA, et al. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med. 2010;38(4):10541059.Google Scholar
Passaretti, CL, Otter, JA, Reich, NG, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis. 2013;56(1):2735.Google Scholar
Nerandzic, MM, Thota, P, Sankar, CT, et al. Evaluation of a pulsed xenon ultraviolet disinfection system for reduction of healthcare-associated pathogens in hospital rooms. Infect Control Hosp Epidemiol. 2015;36(2):192197.Google Scholar
Salgado, CD, Sepkowitz, KA, John, JF, et al. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013;34(5):479486.CrossRefGoogle ScholarPubMed
Byers, KE, Anglim, AM, Anneski, CJ, et al. Duration of colonization with vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol. 2002;23(4):207211.Google Scholar
Donskey, CJ, Hoyen, CK, Das, SM, et al. Recurrence of vancomycin-resistant enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol. 2002;23(8):436440.CrossRefGoogle ScholarPubMed
Henard, S, Lozniewski, A, Aissa, N, et al. Evaluation of the duration of vanA vancomycin-resistant enterococcus faecium carriage and clearance during a large-scale outbreak in a region of eastern France. Am J Infect Control. 2011;39(2):169171.CrossRefGoogle Scholar
Scanvic, A, Denic, L, Gaillon, S, et al. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis. 2001;32(10):13931398.Google Scholar
Harbarth, S, Liassine, N, Dharan, S, et al. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2000;31(6):13801385.Google Scholar
Marschall, J, Muhlemann, K. Duration of methicillin-resistant Staphylococcus aureus carriage, according to risk factors for acquisition. Infect Control Hosp Epidemiol. 2006;27(11):12061212.Google Scholar
Shenoy, ES, Kim, J, Rosenberg, ES, et al. Discontinuation of contact precautions for methicillin-resistant Staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis. 2013;57(2):176184.Google Scholar
Robicsek, A, Beaumont, JL, Paule, SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148(6):409418.Google Scholar
Girou, E, Pujade, G, Legrand, P, et al. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis. 1998;27(3):543550.Google Scholar
Huang, SS, Rifas-Shiman, SL, Pottinger, JM, et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis. 2007;195(3):339346.Google Scholar
Huang, SS, Yokoe, DS, Hinrichsen, VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43(8):971978.Google Scholar
Marshall, C, Richards, M, McBryde, E. Do active surveillance and contact precautions reduce MRSA acquisition? A prospective interrupted time series. PLoS One. 2013;8(3):e58112.Google Scholar
Jain, R, Kralovic, SM, Evans, ME, et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N Engl J Med. 2011;364(15):14191430.Google Scholar
Harbarth, S, Fankhauser, C, Schrenzel, J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299(10):11491157.Google Scholar
Huskins, WC, Huckabee, CM, O’Grady, NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):14071418.Google Scholar
Derde, LP, Cooper, BS, Goossens, H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14(1):3139.CrossRefGoogle ScholarPubMed
Huang, SS, Septimus, E, Kleinman, K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368(24):22552265.Google Scholar
Eveillard, M, de Lassence, A, Lancien, E, et al. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol. 2006;27(2):181184.Google Scholar
Cherkaoui, A, Renzi, G, Francois, P, et al. Comparison of four chromogenic media for culture-based screening of meticillin-resistant Staphylococcus aureus. J Med Microbiol. 2007;56 (Pt 4):500503.Google Scholar
Jeyaratnam, D, Whitty, CJ, Phillips, K, et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ. 2008;336(7650):927930.CrossRefGoogle ScholarPubMed
Roisin, S, Laurent, C, Denis, O, et al. Impact of rapid molecular screening at hospital admission on nosocomial transmission of methicillin-resistant Staphylococcus aureus: Cluster randomised trial. PLoS One. 2014;9(5):e96310.Google Scholar
Dacre, J, Emmerson, AM, Jenner, EA. Gentamicin-methicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreak. J Hosp Infect. 1986;7(2):130136.Google Scholar
Meier, PA, Carter, CD, Wallace, SE, et al. A prolonged outbreak of methicillin-resistant Staphylococcus aureus in the burn unit of a tertiary medical center. Infect Control Hosp Epidemiol. 1996;17(12):798802.Google Scholar
Saiman, L, Cronquist, A, Wu, F, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003;24(5):317321.Google Scholar
Vernon, MO, Hayden, MK, Trick, WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med. 2006;166(3):306312.Google Scholar
Karki, S, Cheng, AC. Impact of non-rinse skin cleansing with chlorhexidine gluconate on prevention of healthcare-associated infections and colonization with multi-resistant organisms: a systematic review. J Hosp Infect. 2012;82(2):7184.Google Scholar
Ridenour, G, Lampen, R, Federspiel, J, et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol. 2007;28(10):11551161.Google Scholar
Evans, HL, Dellit, TH, Chan, J, et al. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg. 2010;145(3):240246.Google Scholar
Noto, MJ, Domenico, HJ, Byrne, DW, et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA. 2015;313(4):369378.Google Scholar
Climo, MW, Sepkowitz, KA, Zuccotti, G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med. 2009;37(6):18581865.CrossRefGoogle ScholarPubMed
Climo, MW, Yokoe, DS, Warren, DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. 2013;368(6):533542.Google Scholar
Lee, AS, Cooper, BS, Malhotra-Kumar, S, et al. Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open. 2013;3(9):e003126003126.Google Scholar
Widner, A, Nobles, DL, Faulk, C, et al. The impact of a “search and destroy” strategy for the prevention of methicillin-resistant Staphylococcus aureus infections in an inpatient rehabilitation facility. PM R. 2014;6(2):121–6; quiz 126.Google Scholar
Kassakian, SZ, Mermel, LA, Jefferson, JA, et al. Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients. Infect Control Hosp Epidemiol. 2011;32(3):238243.Google Scholar
Rupp, ME, Cavalieri, RJ, Lyden, E, et al. Effect of hospital-wide chlorhexidine patient bathing on healthcare-associated infections. Infect Control Hosp Epidemiol. 2012;33(11):10941100.Google Scholar
Wang, X, Panchanathan, S, Chowell, G. A data-driven mathematical model of CA-MRSA transmission among age groups: evaluating the effect of control interventions. PLoS Comput Biol. 2013;9(11):e1003328.Google Scholar
Popoola, VO, Budd, A, Wittig, SM, et al. Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol. 2014;35(4):412418.Google Scholar
Delaney, HM, Wang, E, Melish, M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol. 2013;33(4):313318.Google Scholar
Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013;381(9872):10991106.Google Scholar
Kumar, N, David, MZ, Boyle-Vavra, S, et al. High Staphylococcus aureus colonization prevalence among patients with skin and soft tissue infections and controls in an urban emergency department. J Clin Microbiol. 2015;53(3):810815.Google Scholar
Buehlmann, M, Frei, R, Fenner, L, et al. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol. 2008;29(6):510516.Google Scholar
Hetem, DJ, Bonten, MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect. 2013;85(4):249256.Google Scholar
Lee, AS, Macedo-Vinas, M, Francois, P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis. 2011;52(12):14221430.Google Scholar
Batra, R, Cooper, BS, Whiteley, C, et al. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis. 2010;50(2):210217.Google Scholar
Centers for Disease Control and Prevention. Guide to infection prevention for outpatient settings: minimum expectations for safe care. Available at: www.cdc.gov/HAI/settings/outpatient/outpatient-care-guidelines.html. Accessed January 22, 2016.Google Scholar
Smith, PW, Bennett, G, Bradley, S, et al. SHEA/APIC guideline: infection prevention and control in the long-term care facility. Am J Infect Control. 2008;36(7):504535.Google Scholar

References

World Health Organization (WHO). www.who.int/drugresistance/documents/surveillancereport/en/. Accessed November 12, 2015.Google Scholar
Drees, M, Pineles, L, Harris, AD, Morgan, DJ. Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol. Apr 2014;35(4):362366.Google Scholar
Magiorakos, AP, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. Mar 2012;18(3):268281.Google Scholar
Tacconelli, E, Cataldo, MA, Dancer, SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20 Suppl 1:155.Google Scholar
World Health Organization (WHO). www.cdc.gov/nhsn/pdfs/ps-analysis-resources/phenotype_definitions.pdf. Accessed November 12, 2015.Google Scholar
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; approved standard. Twenty-fourth informational supplement. CLSI Document M100-S24. Wayne, PA: CLSI 2014.Google Scholar
Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):114.Google Scholar
Bush, K. The ABCD’s of B-lactamase nomenclature. J Infect Chemother. 2013; 19(4):549559.Google Scholar
Castanheira, M, Farrell, SE, Krause, KM, Jones, RN, Sader, HS. Contemporary diversity of beta-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent beta-lactamase groups. Antimicrob Agents Chemother. 2014;58(2):833838.Google Scholar
D’Andrea, MM, Arena, F, Pallecchi, L, Rossolini, GM. CTX-M-type beta-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol. Aug 2013;303(6–7):305317.Google Scholar
Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. Nov 2008;29(11):9961011.Google Scholar
Guh, AY, Bulens, SN, Mu, Y, et al. Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012–2013. JAMA. 2015;314(14):14791487.Google Scholar
Perez, F, Van Duin, D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med. Apr 2013;80(4):225233.Google Scholar
Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR. 2013;62(9):165170.Google Scholar
Borer, A, Saidel-Odes, L, Riesenberg, K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972976.Google Scholar
Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):6067.Google Scholar
Satlin, MJ, Jenkins, SG, Walsh, TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):12741283.Google Scholar
Munoz-Price, LS, Poirel, L, Bonomo, RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013; 13(9):785–96.Google Scholar
Nordmann, P, Naas, T, Poirel, L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):17911798.Google Scholar
Kitchel, B, Rasheed, JK, Patel, JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53(8):33653370.Google Scholar
Kaiser, RM, Castanheira, M, Jones, RN, Tenover, F, Lynfield, R. Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007–2009 SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. Jul 2013;76(3):356360.Google Scholar
Kumarasamy, KK, Toleman, MA, Walsh, TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancetl Infect Dis. 2010;10(9):597602.Google Scholar
Mathers, AJ, Hazen, KC, Carroll, J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the New World. J Clin Microbiol. 2013; 51(2)680683.Google Scholar
Centers for Disease Control (CDC). www.cdc.gov/hai/organisms/cre/definition.html. Accessed October 19, 2015.Google Scholar
Chea, N, Bulens, SN, Kongphet-Tran, T, et al. Improved phenotype-based definition for identifying carbapenemase producers among carbapenem-resistant Enterobacteriaceae. Emerg Infect Dis. 2015;21(9):16111616.Google Scholar
Hrabak, J, Chudackova, E, Papagiannitsis, CC. Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin Microbiol Infect. Sep 2014;20(9):839853.CrossRefGoogle ScholarPubMed
Hombach, M, von Gunten, B, Gastelberg, C, et al. Evaluation of the RAPIDEC® CARBA NP test for the detection of carbapenemases in Enterobacteriaceae. J Clin Microbiol 2015 Sep 30. pii: JCM.02327–15. Epub ahead of print.Google Scholar
Nordmann, P, Poirel, L, Dortet, L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):15031507.Google Scholar
Pseudomonas dermatitis/folliculitis associated with pool and hot tubs: Colorado and Maine, 1999–2000. MMW. 2000;49(48):10871091.Google Scholar
Dixon, RS, Sydnor, CH. Puncture wound pseudomonal osteomyelitis of the foot. J Foot Ankle Surg. 1993; 32(4):434442.Google ScholarPubMed
Wieland, M, Lederman, MM, Kline-King, C, et al. Left-sided endocarditis due to Pseudomonas aeruginosa: a report of 10 cases and review of the literature. Medicine (Baltimore). May 1986; 65(3):180189.Google Scholar
Livermore, DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002; 34(5):634640.Google Scholar
Maragakis, LL and Perl, TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46(8):12541263.Google Scholar
Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004. MMWR. 2004;53(45):10631066.Google Scholar
Lolans, K, Rice, TW, Munoz-Price, LS, Quinn, JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother. 2006;50(9):29412945.Google Scholar
Munoz-Price, LS, Arheart, K, Nordmann, P, et al. Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital. Crit Care Med. Dec 2013;41(12):27332742.Google Scholar
Thom, KA, Maragakis, LL, Richards, K, et al. Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey. Infect Control Hosp Epidemiol. Sep 2012;33(9):883888.Google Scholar
Harris, AD, McGregor, JC, Furuno, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis Sept 2006:43 Suppl 2:S57S61.Google Scholar
Williams, C, McGraw, P, Schneck, EE, et al. Impact of universal gowning and gloving on health care worker clothing contamination. Infect Control Hosp Epidemiol. 2015;36(4):431437.Google Scholar
Hayden, MK, Blom, DW, Lyle, EA, Moore, CG, Weinstein, RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients’ environment. Infect Control Hosp Epidemiol. 2008;29(2):149154.Google Scholar
Snyder, GM, Thom, KA, Furuno, JP, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol. 2008;29(7):583589.Google Scholar
Morgan, DJ, Liang, SY, Smith, CL, et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol. 2010;31(7):716721.Google Scholar
Harris, AD, Perencevich, EN, Johnson, JK, et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45(10):13471350.Google Scholar
Harris, AD, Kotetishvili, M, Shurland, S, et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Contrl. 2007;35(2):97101.Google Scholar
Rock, C, Thom, KA, Masnick, M, Johnson, JK, Harris, AD, Morgan, DJ. Frequency of Klebsiella pneumoniae carbapenemase (KPC)-producing and non-KPC-producing Klebsiella species contamination of healthcare workers and the environment. Infect Control Hosp Epidemiol. 2014;35(4):426429.Google Scholar
Cohen, CC, Cohen, B, Shang, J. Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature. J Hosp Infect. 2015;90(4):275284.Google Scholar
Kho, AN, Dexter, PR, Warvel, JS, et al. An effective computerized reminder for contact isolation of patients colonized or infected with resistant organisms. Int J Med Informatics. 2008;77(3):194198.Google Scholar
Palmore, TN, Henderson, DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis. 2013;57(11):15931599.Google Scholar
Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 1 2011;52(7):848855.Google Scholar
Lucet, JC, Decre, D, Fichelle, A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29(6):14111418.Google Scholar
Tamma, PD, Savard, P, Pal, T, Sonnevend, A, Perl, TM, Milstone, AM. An outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2012;33(6):631634.CrossRefGoogle Scholar
Munoz-Price, LS, Hayden, MK, Lolans, K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010;31(4):341347.Google Scholar
Munoz-Price, LS, Quinn, JP. Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Op Infect Dis. 2013;26(4):378387.Google Scholar
Schwaber, MJ, Carmeli, Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis. Mar 2014;58(5):697703.Google Scholar
Kramer, A, Schwebke, I, Kampf, G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130.Google Scholar
Denton, M, Wilcox, MH, Parnell, P, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. Intensive Crit Care Nurs. Ar 2005;21(2):9498.Google Scholar
Carling, PC, Parry, MF, Bruno-Murtha, LA, Dick, B. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med. Apr 2010;38(4):10541059.CrossRefGoogle ScholarPubMed
Contamination, Hota B., disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis. Oct 2004;39(8):11821189.Google Scholar
Boyce, JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. Jun 2007;65, Suppl 2:5054.CrossRefGoogle ScholarPubMed
Jawad, A, Seifert, H, Snelling, AM, Heritage, J, Hawkey, PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36(7):19381941.Google Scholar
Levin, AS, Gobara, S, Mendes, CM, Cursino, MR, Sinto, S. Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit. Infect Control Hosp Epidemiol. Nov 2001;22(11):717720.Google Scholar
Catalano, M, Quelle, LS, Jeric, PE, Di Martino, A, Maimone, SM. Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect. 1999;42(1):2735.CrossRefGoogle ScholarPubMed
Das, I, Lambert, P, Hill, D, Noy, M, Bion, J, Elliott, T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect. 2002;50(2):110114.Google Scholar
Aygun, G, Demirkiran, O, Utku, T, et al. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect. 2002;52(4):259262.Google Scholar
Anaissie, EJ, Penzak, SR, Dignani, MC. The hospital water supply as a source of nosocomial infections: a plea for action. Arch Intern Med. 2002;162(13):14831492.Google Scholar
Bonten, MJ, Weinstein, RA. Transmission pathways of Pseudomonas aeruginosa in intensive care units: don’t go near the water. Crit Care Med. 2002;30(10):23842385.Google Scholar
Epstein, L, Hunter, JC, Arwady, MA, et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312(14):14471455.Google Scholar
Ha, J, Son, BK. Current Issues in duodenoscope-associated infections: now is the time to take action. Clin Endoscopy. 2015;48(5):361363.Google Scholar
Muscarella, LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endoscopy. 2014;6(10):457474.Google Scholar
Calfee, D, Jenkins, SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol. 2008;29(10):966968.Google Scholar
Snitkin, ES, Zelazny, AM, Thomas, PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Translational Med. 2012;4(148):148ra116.CrossRefGoogle ScholarPubMed
Akduman, B, Akduman, D, Tokgoz, H, et al. Long-term fluoroquinolone use before prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology. 2011; 78(2):250255.Google Scholar
Boucher, HW, Talbot, GH, Bradley, JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(1):112.Google Scholar
Hsu, AJ and Tamma, PD. Treatment of multidrug-resistant Gram-negative infections in children. Clin Infect Dis May 2014; 58(10):14391448.Google Scholar
Centers for Disease Control and Prevention (CDC). Centers for Disease Control (CDE). www.cdc.gov/drugresistance/pdf/ar-threats-2013–508.pdf. Accessed November 13, 2015.Google Scholar
Tamma, PD and Cosgrove, SE. Antimicrobial stewardship. Infec Dis Clin North Am 2011; 25(1):245260.Google Scholar
Marchaim, D, Chopra, T, Bhargava, A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817830.Google Scholar
Carmeli, Y, Lidji, SK, Shabtai, E, Navon-Venezia, S, Schwaber, MJ. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study. Diagn Microbiol Infect Dis. 2011;70(3):367372.Google Scholar
Dortch, MJ, Fleming, SB, Kauffmann, RM, Dossett, LA, Talbot, TR, May, AK. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infecti. 2011;12(1):1525.Google Scholar
Rahal, JJ, Urban, C, Horn, C, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):12331237.Google Scholar
Ntagiopoulos, PG, Paramythiotou, E, Antoniadou, A, et al. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents. 2007; 30:360365.Google Scholar
Altunsoy, A, Aypak, C, Azap, A, et al. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci. 2011;4:339344.Google Scholar
Davey, P, Brown, E, Charani, E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Systematic Review Apr 20134:CD003543. doi:10.1002/14651858.CD003543.pub3.Google Scholar
Roquilly, A, Marret, E, Abraham, E, Asehnoune, K. Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin Infect Dis. 2015;60(1):6475.Google Scholar
Price, R, MacLennan, G, Glen, J, Su, DC. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ. 2014;348:g2197.CrossRefGoogle ScholarPubMed
de Smet, AM, Kluytmans, JA, Blok, HE, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis. 2011;11(5):372380.Google Scholar
Oostdijk, EA, Kesecioglu, J, Schultz, MJ, et al. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA. 2014;312(14):14291437.Google Scholar
Lin, MY, Lolans, K, Blom, DW, et al. The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol. 2014;35(4):440442.Google Scholar
Septimus, EJ, Hayden, MK, Kleinman, K, et al. Does chlorhexidine bathing in adult intensive care units reduce blood culture contamination? A pragmatic cluster-randomized trial. Infect Control Hosp Epidemiol. 2014; 35 Suppl 3:S17S22.Google Scholar
Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013;381(9872):10991106.CrossRefGoogle ScholarPubMed
Climo, MW, Yokoe, DS, Warren, DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. Feb 7 2013;368(6):533542.Google Scholar
Climo, MW, Sepkowitz, KA, Zuccotti, G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med. 2009;37(6):18581865.Google Scholar
Hayden, MK, Lin, MY, Lolans, K, et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis. 2015;60(8):11531161.Google Scholar
Brooks, SE, Walczak, MA, Hameed, R, et al. Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine. Infect Control Hosp Epidemiol. 2002; 23(11):692695.Google Scholar
Tattawasart, U, Maillard, JY, Furr, JR, Russell, AD. Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine diacetate and cetylpyridinium chloride. Int J Antimicrob Agents. 2000;16(3):233238.Google Scholar
Thomas, L, Maillard, JY, Lambert, RJ, Russell, AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a “residual” concentration. J Hosp Infect. 2000;46(4):297303.Google Scholar
Higgins, CS, Murtough, SM, Williamson, E, et al. Resistance to antibiotics and biocides among non-fermenting Gram-negative bacteria. Clin Microbiol Infect. 2001;7(6):308315.Google Scholar
Hilty, M, Betsch, BY, Bogli-Stuber, K, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55(7):967975.Google Scholar
Madigan, T, Johnson, JR, Clabots, C, et al. Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum beta-lactamase-producing Escherichia coli sequence type 131. Clin Infect Dis. 2015;61(1):e512.Google Scholar
Doi, Y, Park, YS, Rivera, JI, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641648.Google Scholar
Gould, CV, Rothenberg, R, Steinberg, JP. Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol. 2006;27(9):920925.Google Scholar
O’Fallon, E, Pop-Vicas, A, The Emerging, D’Agata E. Threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Ger Ser A. 2009; 64(1):138141.Google Scholar
Mills, JP, Talati, NJ, Alby, K, Han, JH. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol. 12 2015:16.Google Scholar
Lin, MY, Lyles-Banks, RD, Lolans, K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57(9):12461252.Google Scholar
O’Fallon, E, Gautam, S, D’ Agata, EM. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent colonization. Clin Infect Dis. 2009;48(10):13751381.Google Scholar
Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Healthcare Infection Control Practices Advisory C: management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165S193.Google Scholar
Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Health Care Infection Control Practices Advisory C. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35(10 Suppl 2):S65S164.Google Scholar
Centers for Disease Control and Prevention (CDC). ww.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Accessed November 13th, 2015.Google Scholar
Feldman, N, Adler, A, Molshatzki, N, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect. 2013;19(4):E190196.Google Scholar
Oren, I, Sprecher, H, Finkelstein, R, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infecti Control. 2013;41(12):11671172.Google Scholar

Reference List

Bartlett, JG. Clostridium difficile infection: historic review. Anaerobe. 2009;15(6):227229.Google Scholar
Kelly, CP, Pothoulakis, C, LaMont, JT. Clostridium difficile colitis. N Engl J Med. 1994;330(4):257262.Google Scholar
Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):11981208.Google Scholar
Kwon, JH, Olsen, MA, Dubberke, ER. The morbidity, mortality, and costs associated with Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):123134.Google Scholar
Bartlett, JG. Narrative review: the new epidemic of Clostridium difficile–associated enteric disease. Ann Intern Med. 2006;145(10):758764.Google Scholar
Honda, H, Dubberke, ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol. 2014;30(1):5462.Google Scholar
al Saif, N, Brazier, JS. The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol. 1996;45(2):133137.Google Scholar
Bakri, MM, Brown, DJ, Butcher, JP, Sutherland, AD. Clostridium difficile in ready-to-eat salads, Scotland. Emerg Infect Dis. 2009;15(5):817818.Google Scholar
Gould, LH, Limbago, B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis. 2010;51(5):577582.Google Scholar
Songer, JG, Trinh, HT, Killgore, GE, Thompson, AD, McDonald, LC, Limbago, BM. Clostridium difficile in retail meat products, USA, 2007. Emerg Infect Dis. 2009;15(5):819–21.Google Scholar
Rupnik, M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect. 2007;13(5):457459.Google Scholar
Muto, CA, Blank, MK, Marsh, JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis. 2007;45(10):12661273.Google Scholar
Lessa, FC, Mu, Y, Bamberg, WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825834.Google Scholar
Dubberke, ER, Schaefer, E, Reske, KA, Zilberberg, M, Hollenbeak, CS, Olsen, MA. Attributable inpatient costs of recurrent Clostridium difficile infections. Infect Control Hosp Epidemiol. 2014;35(11):14001407.Google Scholar
Chitnis, AS, Holzbauer, SM, Belflower, RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173(14):13591367.Google Scholar
Alasmari, F, Seiler, SM, Hink, T, Burnham, CA, Dubberke, ER. Prevalence and risk factors for asymptomatic Clostridium difficile carriage. Clin Infect Dis. 2014;59(2):216222.Google Scholar
Fekety, R, Kim, KH, Brown, D, Batts, DH, Cudmore, M, Silva, J, Jr. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med. 1981;70(4):906908.Google Scholar
Jump, RL, Pultz, MJ, Donskey, CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother. 2007;51(8):28832887.Google Scholar
McFarland, LV, Mulligan, ME, Kwok, RY, Stamm, WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320(4):204210.Google Scholar
Sunenshine, RH, McDonald, LC. Clostridium difficile–associated disease: new challenges from an established pathogen. Cleve Clin J Med. 2006;73(2):187197.Google Scholar
Hurley, BW, Nguyen, CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med. 2002;162(19):21772184.CrossRefGoogle ScholarPubMed
Donskey, CJ. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis. 2004;39(2):219226.Google Scholar
Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431455.Google Scholar
Loo, VG, Bourgault, AM, Poirier, L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):16931703.Google Scholar
Olsen, MA, Stwalley, D, Demont, C, Mahe, C, Dubberke, ER. Minimal contribution of age to risk of Clostridium difficile infection in the elderly. ID Week. 2015. 10-8-2015.Google Scholar
Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):115.Google Scholar
Dubberke, ER, Reske, KA, Seiler, S, Hink, T, Kwon, JH, Burnham, CA. Risk factors for acquisition and loss of C. difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;.Google Scholar
McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678684.Google Scholar
Zacharioudakis, IM, Zervou, FN, Pliakos, EE, Ziakas, PD, Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381390.Google Scholar
Bagdasarian, N, Rao, K, Malani, PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398408.Google Scholar
Wanahita, A, Goldsmith, EA, Musher, DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34(12):15851592.Google Scholar
Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):28872893.CrossRefGoogle ScholarPubMed
Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12S18.Google Scholar
Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373378.Google Scholar
Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol. 2003;41(2):531534.Google Scholar
Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med. 2015;12.Google Scholar
Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):37953797.Google Scholar
Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459477.CrossRefGoogle ScholarPubMed
Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):11451149.Google Scholar
Shanholtzer, CJ, Willard, KE, Holter, JJ, Olson, MM, Gerding, DN, Peterson, LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol. 1992;30(7):18371840.Google Scholar
Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):6773.Google Scholar
van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43(10):53385340.Google Scholar
Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334339.Google Scholar
Shannon-Lowe, J, Matheson, NJ, Cooke, FJ, Aliyu, SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.Google Scholar
Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422431.Google Scholar
Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345354.Google Scholar
Johnson, S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403410.Google Scholar
Garey, KW, Ghantoji, SS, Shah, DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011;66(12):28502855.Google Scholar
Soriano, MM, Danziger, LH, Gerding, DN, Johnson, S. Novel fidaxomicin treatment regimens for patients with multiple clostridium difficile infection recurrences that are refractory to standard therapies. Open Forum Infect Dis. 2014;1(2):ofu069.Google Scholar
Cammarota, G, Ianiro, G, Gasbarrini, A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014 Jan 16.Google Scholar
Hirsch, BE, Saraiya, N, Poeth, K, Schwartz, RM, Epstein, ME, Honig, G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015;15:191.Google Scholar
Orenstein, R, Dubberke, E, Hardi, R, et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD Study. Clin Infect Dis. 2015 Nov 12.Google Scholar
van Nood, E, Vrieze, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407415.Google Scholar
Youngster, I, Russell, GH, Pindar, C, Ziv-Baran, T, Sauk, J, Hohmann, EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):17721778.Google Scholar
Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies, Food and Drug Administration, (2013).Google Scholar
Allen, SJ. The potential of probiotics to prevent Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):135144.Google Scholar
Gerding, DN, Muto, CA, Owens, RC, Jr. Treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S32S42.Google Scholar
Byrn, JC, Maun, DC, Gingold, DS, Baril, DT, Ozao, JJ, Divino, CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150154.Google Scholar
Lamontagne, F, Labbe, AC, Haeck, O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267272.Google Scholar
Pepin, J, Vo, TT, Boutros, M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52(3):400405.Google Scholar
Sailhamer, EA, Carson, K, Chang, Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433439.Google Scholar
Neal, MD, Alverdy, JC, Hall, DE, Simmons, RL, Zuckerbraun, BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423427.Google Scholar
Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014;35(8):967977.Google Scholar
Dubberke, ER, McMullen, KM, Mayfield, JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol. 2009;30(4):332337.Google Scholar
Dubberke, ER, Butler, AM, Hota, B, et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009;30(6):518525.Google Scholar
Marschall, J, Mermel, LA, Fakih, M, et al. Strategies to prevent central line–associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753771.Google Scholar
Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):27252732.Google Scholar
Warren, DK, Zack, JE, Cox, MJ, Cohen, MM, Fraser, VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med. 2003;31(7):19591963.Google Scholar
Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(6):628645.Google Scholar
Weiss, K, Boisvert, A, Chagnon, M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009;30(2):156162.Google Scholar
Gravel, D, Gardam, M, Taylor, G, et al. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada. Am J Infect Control. 2009;37(1):914.Google Scholar
Wilkinson, K, Gravel, D, Taylor, G, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177182.Google Scholar
Detsky, ME, Etchells, E. Single-patient rooms for safe patient-centered hospitals. JAMA. 2008;300(8):954956.Google Scholar
Kundrapu, S, Jury, LA, Sitzlar, B, Sunkesula, VC, Sethi, AK, Donskey, CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol. 2013;51(7):23652370.Google Scholar
Boyce, JM, Pittet, D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-16):145, quiz.Google Scholar
Landelle, C, Verachten, M, Legrand, P, Girou, E, Barbut, F, Buisson, CB. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):1015.Google Scholar
Edmonds, SL, Zapka, C, Kasper, D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2013;34(3):302305.Google Scholar
Shaughnessy, MK, Micielli, RL, Depestel, DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201206.Google Scholar
Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect. 2009;71(1):4956.Google Scholar
Kim, KH, Fekety, R, Batts, DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):4250.Google Scholar
Dumford, DM III, Nerandzic, MM, Eckstein, BC, Donskey, CJ. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control. 2009;37(1):1519.Google Scholar
Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100(1):3240.Google Scholar
Cunningham, R, Dale, B, Undy, B, Gaunt, N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243245.Google Scholar
Merrigan, M, Venugopal, A, Mallozzi, M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):49044911.Google Scholar
Dubberke, ER, Reske, KA, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control. 2007;35(5):315318.Google Scholar
Curry, SR, Muto, CA, Schlackman, JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):10941102.Google Scholar
Eyre, DW, Griffiths, D, Vaughan, A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One. 2013;8(11):e78445.Google Scholar
Kaatz, GW, Gitlin, SD, Schaberg, DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988;127(6):12891294.Google Scholar
McMullen, KM, Zack, J, Coopersmith, CM, Kollef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol. 2007;28(2):205207.Google Scholar
Orenstein, R, Aronhalt, KC, McManus, JE Jr., Fedraw, LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011;32(11):1137–119.Google Scholar
Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31(4):9951000.Google Scholar
Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54(2):109114.Google Scholar
Barbut, F, Menuet, D, Verachten, M, Girou, E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30(6):507514.Google Scholar
Boyce, JM, Havill, NL, Otter, JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29(8):723729.Google Scholar
Sitzlar, B, Deshpande, A, Fertelli, D, Kundrapu, S, Sethi, AK, Donskey, CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459465.Google Scholar
Anderson, D, Chen, LF, Weber, DJ, et al. The benefits of enhanced terminal room (betr) disinfection study: a cluster randomized, multicenter crossover study with 2x2 factorial design to evaluate the impact of enhanced terminal room disinfection on acquisition and infection caused by multidrug-resistant organisms (MDRO). ID Week. 2015. 10-9-2015.Google Scholar
Boyce, JM, Havill, NL, Dumigan, DG, Golebiewski, M, Balogun, O, Rizvani, R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30(7):678684.Google Scholar
Carling, PC, Parry, MF, Von Beheren, SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):17.Google Scholar
Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159177.Google Scholar
Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194200.Google Scholar
Levin, PD, Idrees, S, Sprung, CL, et al. Antimicrobial use in the ICU: indications and accuracy–an observational trial. J Hosp Med. 2012;7(9):672678.Google Scholar
Camins, BC, King, MD, Wells, JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol. 2009;30(10):931938.Google Scholar
Owens, RC Jr., Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008 ;46 Suppl 1:S19S31.Google Scholar
Nuila, F, Cadle, RM, Logan, N, Musher, DM. Antibiotic stewardship and Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2008;29(11):10961097.Google Scholar
Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112S121.Google Scholar
Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.Google Scholar
Pattani, R, Palda, VA, Hwang, SW, Shah, PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 2013;7(2):e56e67.Google Scholar
Johnson, S, Maziade, PJ, McFarland, LV, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis. 2012;16(11):e786e792.Google Scholar
Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):15431549.Google Scholar
Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31(10):10301037.Google Scholar
Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):24422449.Google Scholar
Gao, XW, Mubasher, M, Fang, CY, Reifer, C, Miller, LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80 R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):16361641.Google Scholar
Kotowska, M, Albrecht, P, Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583590.Google Scholar
Hennequin, C, Kauffmann-Lacroix, C, Jobert, A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19(1):1620.Google Scholar
Enache-Angoulvant, A, Hennequin, C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41(11):15591568.Google Scholar
Gouriet, F, Million, M, Henri, M, Fournier, PE, Raoult, D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis. 2012;31(9):24692480.Google Scholar
Eyre, DW, Cule, ML, Wilson, DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):11951205.Google Scholar
Lanzas, C, Dubberke, ER, Lu, Z, Reske, KA, Grohn, YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553561.CrossRefGoogle ScholarPubMed
McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015;175(5):784791.Google Scholar
Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):115.Google Scholar
Dubberke, ER, Reske, KA, Seiler, S, Hink, T, Kwon, JH, Burnham, CA. Risk factors for acquisition and loss of C. difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;.Google Scholar
McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678684.Google Scholar
Zacharioudakis, IM, Zervou, FN, Pliakos, EE, Ziakas, PD, Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381390.Google Scholar
Bagdasarian, N, Rao, K, Malani, PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398408.Google Scholar
Wanahita, A, Goldsmith, EA, Musher, DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34(12):15851592.Google Scholar
Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):28872893.CrossRefGoogle ScholarPubMed
Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12S18.Google Scholar
Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373378.Google Scholar
Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol. 2003;41(2):531534.Google Scholar
Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med. 2015;12.Google Scholar
Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):37953797.Google Scholar
Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459477.CrossRefGoogle ScholarPubMed
Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):11451149.Google Scholar
Shanholtzer, CJ, Willard, KE, Holter, JJ, Olson, MM, Gerding, DN, Peterson, LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol. 1992;30(7):18371840.Google Scholar
Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):6773.Google Scholar
van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43(10):53385340.Google Scholar
Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334339.Google Scholar
Shannon-Lowe, J, Matheson, NJ, Cooke, FJ, Aliyu, SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.Google Scholar
Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422431.Google Scholar
Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345354.Google Scholar
Johnson, S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403410.Google Scholar
Garey, KW, Ghantoji, SS, Shah, DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011;66(12):28502855.Google Scholar
Soriano, MM, Danziger, LH, Gerding, DN, Johnson, S. Novel fidaxomicin treatment regimens for patients with multiple clostridium difficile infection recurrences that are refractory to standard therapies. Open Forum Infect Dis. 2014;1(2):ofu069.Google Scholar
Cammarota, G, Ianiro, G, Gasbarrini, A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol. 2014 Jan 16.Google Scholar
Hirsch, BE, Saraiya, N, Poeth, K, Schwartz, RM, Epstein, ME, Honig, G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis. 2015;15:191.Google Scholar
Orenstein, R, Dubberke, E, Hardi, R, et al. Safety and durability of RBX2660 (microbiota suspension) for recurrent Clostridium difficile infection: results of the PUNCH CD Study. Clin Infect Dis. 2015 Nov 12.Google Scholar
van Nood, E, Vrieze, A, Nieuwdorp, M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013;368(5):407415.Google Scholar
Youngster, I, Russell, GH, Pindar, C, Ziv-Baran, T, Sauk, J, Hohmann, EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA. 2014;312(17):17721778.Google Scholar
Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies, Food and Drug Administration, (2013).Google Scholar
Allen, SJ. The potential of probiotics to prevent Clostridium difficile infection. Infect Dis Clin North Am. 2015;29(1):135144.Google Scholar
Gerding, DN, Muto, CA, Owens, RC, Jr. Treatment of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S32S42.Google Scholar
Byrn, JC, Maun, DC, Gingold, DS, Baril, DT, Ozao, JJ, Divino, CM. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg. 2008;143(2):150154.Google Scholar
Lamontagne, F, Labbe, AC, Haeck, O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg. 2007;245(2):267272.Google Scholar
Pepin, J, Vo, TT, Boutros, M, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009;52(3):400405.Google Scholar
Sailhamer, EA, Carson, K, Chang, Y, et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009;144(5):433439.Google Scholar
Neal, MD, Alverdy, JC, Hall, DE, Simmons, RL, Zuckerbraun, BS. Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg. 2011;254(3):423427.Google Scholar
Yokoe, DS, Anderson, DJ, Berenholtz, SM, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals: 2014 updates. Infect Control Hosp Epidemiol. 2014;35(8):967977.Google Scholar
Dubberke, ER, McMullen, KM, Mayfield, JL, et al. Hospital-associated Clostridium difficile infection: is it necessary to track community-onset disease? Infect Control Hosp Epidemiol. 2009;30(4):332337.Google Scholar
Dubberke, ER, Butler, AM, Hota, B, et al. Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol. 2009;30(6):518525.Google Scholar
Marschall, J, Mermel, LA, Fakih, M, et al. Strategies to prevent central line–associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(7):753771.Google Scholar
Pronovost, P, Needham, D, Berenholtz, S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):27252732.Google Scholar
Warren, DK, Zack, JE, Cox, MJ, Cohen, MM, Fraser, VJ. An educational intervention to prevent catheter-associated bloodstream infections in a nonteaching, community medical center. Crit Care Med. 2003;31(7):19591963.Google Scholar
Dubberke, ER, Carling, P, Carrico, R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infect Control Hosp Epidemiol. 2014;35(6):628645.Google Scholar
Weiss, K, Boisvert, A, Chagnon, M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol. 2009;30(2):156162.Google Scholar
Gravel, D, Gardam, M, Taylor, G, et al. Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada. Am J Infect Control. 2009;37(1):914.Google Scholar
Wilkinson, K, Gravel, D, Taylor, G, et al. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Am J Infect Control. 2011;39(3):177182.Google Scholar
Detsky, ME, Etchells, E. Single-patient rooms for safe patient-centered hospitals. JAMA. 2008;300(8):954956.Google Scholar
Kundrapu, S, Jury, LA, Sitzlar, B, Sunkesula, VC, Sethi, AK, Donskey, CJ. Easily modified factors contribute to delays in diagnosis of Clostridium difficile infection: a cohort study and intervention. J Clin Microbiol. 2013;51(7):23652370.Google Scholar
Boyce, JM, Pittet, D. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep. 2002;51(RR-16):145, quiz.Google Scholar
Landelle, C, Verachten, M, Legrand, P, Girou, E, Barbut, F, Buisson, CB. Contamination of healthcare workers’ hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(1):1015.Google Scholar
Edmonds, SL, Zapka, C, Kasper, D, et al. Effectiveness of hand hygiene for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2013;34(3):302305.Google Scholar
Shaughnessy, MK, Micielli, RL, Depestel, DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201206.Google Scholar
Starr, JM, Campbell, A, Renshaw, E, Poxton, IR, Gibson, GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect. 2009;71(1):4956.Google Scholar
Kim, KH, Fekety, R, Batts, DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis. 1981;143(1):4250.Google Scholar
Dumford, DM III, Nerandzic, MM, Eckstein, BC, Donskey, CJ. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains. Am J Infect Control. 2009;37(1):1519.Google Scholar
Samore, MH, Venkataraman, L, DeGirolami, PC, Arbeit, RD, Karchmer, AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med. 1996;100(1):3240.Google Scholar
Cunningham, R, Dale, B, Undy, B, Gaunt, N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect. 2003;54(3):243245.Google Scholar
Merrigan, M, Venugopal, A, Mallozzi, M, et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol. 2010;192(19):49044911.Google Scholar
Dubberke, ER, Reske, KA, Noble-Wang, J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control. 2007;35(5):315318.Google Scholar
Curry, SR, Muto, CA, Schlackman, JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):10941102.Google Scholar
Eyre, DW, Griffiths, D, Vaughan, A, et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One. 2013;8(11):e78445.Google Scholar
Kaatz, GW, Gitlin, SD, Schaberg, DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol. 1988;127(6):12891294.Google Scholar
McMullen, KM, Zack, J, Coopersmith, CM, Kollef, M, Dubberke, E, Warren, DK. Use of hypochlorite solution to decrease rates of Clostridium difficile–associated diarrhea. Infect Control Hosp Epidemiol. 2007;28(2):205207.Google Scholar
Orenstein, R, Aronhalt, KC, McManus, JE Jr., Fedraw, LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011;32(11):1137–119.Google Scholar
Mayfield, JL, Leet, T, Miller, J, Mundy, LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis. 2000;31(4):9951000.Google Scholar
Wilcox, MH, Fawley, WN, Wigglesworth, N, Parnell, P, Verity, P, Freeman, J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54(2):109114.Google Scholar
Barbut, F, Menuet, D, Verachten, M, Girou, E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30(6):507514.Google Scholar
Boyce, JM, Havill, NL, Otter, JA, et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol. 2008;29(8):723729.Google Scholar
Sitzlar, B, Deshpande, A, Fertelli, D, Kundrapu, S, Sethi, AK, Donskey, CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol. 2013;34(5):459465.Google Scholar
Anderson, D, Chen, LF, Weber, DJ, et al. The benefits of enhanced terminal room (betr) disinfection study: a cluster randomized, multicenter crossover study with 2x2 factorial design to evaluate the impact of enhanced terminal room disinfection on acquisition and infection caused by multidrug-resistant organisms (MDRO). ID Week. 2015. 10-9-2015.Google Scholar
Boyce, JM, Havill, NL, Dumigan, DG, Golebiewski, M, Balogun, O, Rizvani, R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30(7):678684.Google Scholar
Carling, PC, Parry, MF, Von Beheren, SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):17.Google Scholar
Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159177.Google Scholar
Fridkin, S, Baggs, J, Fagan, R, et al. Vital signs: improving antibiotic use among hospitalized patients. MMWR Morb Mortal Wkly Rep. 2014;63(9):194200.Google Scholar
Levin, PD, Idrees, S, Sprung, CL, et al. Antimicrobial use in the ICU: indications and accuracy–an observational trial. J Hosp Med. 2012;7(9):672678.Google Scholar
Camins, BC, King, MD, Wells, JB, et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect Control Hosp Epidemiol. 2009;30(10):931938.Google Scholar
Owens, RC Jr., Donskey, CJ, Gaynes, RP, Loo, VG, Muto, CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis. 2008 ;46 Suppl 1:S19S31.Google Scholar
Nuila, F, Cadle, RM, Logan, N, Musher, DM. Antibiotic stewardship and Clostridium difficile–associated disease. Infect Control Hosp Epidemiol. 2008;29(11):10961097.Google Scholar
Valiquette, L, Cossette, B, Garant, MP, Diab, H, Pepin, J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile–associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45 Suppl 2:S112S121.Google Scholar
Goldenberg, JZ, Ma, SS, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;5:CD006095.Google Scholar
Pattani, R, Palda, VA, Hwang, SW, Shah, PS. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med. 2013;7(2):e56e67.Google Scholar
Johnson, S, Maziade, PJ, McFarland, LV, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis. 2012;16(11):e786e792.Google Scholar
Dubberke, ER, Reske, KA, Yan, Y, Olsen, MA, McDonald, LC, Fraser, VJ. Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):15431549.Google Scholar
Dubberke, ER, Butler, AM, Yokoe, DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31(10):10301037.Google Scholar
Loo, VG, Poirier, L, Miller, MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):24422449.Google Scholar
Gao, XW, Mubasher, M, Fang, CY, Reifer, C, Miller, LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80 R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):16361641.Google Scholar
Kotowska, M, Albrecht, P, Szajewska, H. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther. 2005;21(5):583590.Google Scholar
Hennequin, C, Kauffmann-Lacroix, C, Jobert, A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis. 2000;19(1):1620.Google Scholar
Enache-Angoulvant, A, Hennequin, C. Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis. 2005;41(11):15591568.Google Scholar
Gouriet, F, Million, M, Henri, M, Fournier, PE, Raoult, D. Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis. 2012;31(9):24692480.Google Scholar
Eyre, DW, Cule, ML, Wilson, DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med. 2013;369(13):11951205.Google Scholar
Lanzas, C, Dubberke, ER, Lu, Z, Reske, KA, Grohn, YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol. 2011;32(6):553561.CrossRefGoogle ScholarPubMed
McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015;175(5):784791.Google Scholar
Bignardi, GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40(1):115.Google Scholar
Dubberke, ER, Reske, KA, Seiler, S, Hink, T, Kwon, JH, Burnham, CA. Risk factors for acquisition and loss of C. difficile colonization in hospitalized patients. Antimicrob Agents Chemother. 2015;.Google Scholar
McFarland, LV, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162(3):678684.Google Scholar
Zacharioudakis, IM, Zervou, FN, Pliakos, EE, Ziakas, PD, Mylonakis, E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol. 2015;110(3):381390.Google Scholar
Bagdasarian, N, Rao, K, Malani, PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA. 2015;313(4):398408.Google Scholar
Wanahita, A, Goldsmith, EA, Musher, DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by Clostridium difficile. Clin Infect Dis. 2002;34(12):15851592.Google Scholar
Dubberke, ER, Han, Z, Bobo, L, et al. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011;49(8):28872893.CrossRefGoogle ScholarPubMed
Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis. 2008;46 Suppl 1:S12S18.Google Scholar
Stamper, PD, Alcabasa, R, Aird, D, et al. Comparison of a commercial real-time PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol. 2009;47(2):373378.Google Scholar
Wilkins, TD, Lyerly, DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol. 2003;41(2):531534.Google Scholar
Dubberke, ER, Burnham, CD. Diagnosis of Clostridium difficile infection: treat the patient, not the test. JAMA Intern Med. 2015;12.Google Scholar
Aichinger, E, Schleck, CD, Harmsen, WS, Nyre, LM, Patel, R. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol. 2008;46(11):37953797.Google Scholar
Gerding, DN, Johnson, S, Peterson, LR, Mulligan, ME, Silva, J, Jr. Clostridium difficile–associated diarrhea and colitis. Infect Control Hosp Epidemiol. 1995;16(8):459477.CrossRefGoogle ScholarPubMed
Ticehurst, JR, Aird, DZ, Dam, LM, Borek, AP, Hargrove, JT, Carroll, KC. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol. 2006;44(3):11451149.Google Scholar
Shanholtzer, CJ, Willard, KE, Holter, JJ, Olson, MM, Gerding, DN, Peterson, LR. Comparison of the VIDAS Clostridium difficile toxin A immunoassay with C. difficile culture and cytotoxin and latex tests. J Clin Microbiol. 1992;30(7):18371840.Google Scholar
Longtin, Y, Trottier, S, Brochu, G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis. 2013;56(1):6773.Google Scholar
van den Berg, RJ, Bruijnesteijn van Coppenraet, LS, Gerritsen, HJ, Endtz, HP, van der Vorm, ER, Kuijper, EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile–associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43(10):53385340.Google Scholar
Bartlett, JG. Clinical practice: antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334339.Google Scholar
Shannon-Lowe, J, Matheson, NJ, Cooke, FJ, Aliyu, SH. Prevention and medical management of Clostridium difficile infection. BMJ. 2010;340:c1296.Google Scholar
Louie, TJ, Miller, MA, Mullane, KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422431.Google Scholar
Johnson, S, Louie, TJ, Gerding, DN, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis. 2014;59(3):345354.Google Scholar
Johnson, S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009;58(6):403410.Google Scholar
Garey, KW, Ghantoji, SS, Shah, DN, et al. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011;66(12):28502855.Google Scholar